Literature DB >> 3102950

Regulation of interleukin-2 receptor expression and receptor release.

T Diamantstein, H Osawa, A Mouzaki, O Josimovic-Alasevic.   

Abstract

The generation and cell surface expression of IL-2 receptors was monitored by: (i) an ELISA that permits quantitative determination of detergent-solubilized or soluble IL-2 receptors; and (ii) detection of the binding of 125I-labelled recombinant IL-2 and of anti-IL-2 receptor antibodies to receptor bearing cells. Upon lectin stimulation both high and low affinity IL-2 receptors became expressed in parallel at the cell surface. Both high and low affinity receptors were upregulated by IL-2. Upon lectin activation the amount of cell-associated receptors increased and on day 2 of the culture period IL-2 receptors were detectable in the culture supernatant. IL-2 upregulated both high and low affinity IL-2R expression on T-lymphoblasts. IL-2R bearing leukemic cells and T lymphoblasts released IL-2R when cultured in vitro. IL-2R release by T lymphoblasts was enhanced dramatically by IL-2. On the other hand, IL-2-receptor positive leukemic cells released receptors in an IL-2 independent manner. Release of receptors could also be detected in serum-free medium. At least a part of the released receptors could be specifically bound to immobilized pure recombinant IL-2 and to monoclonal anti-IL-2-receptor antibodies. Small but significant amounts of soluble IL-2 receptors were detectable in the sera of normal mice. In sera of mice inoculated with IL-2-receptor positive syngeneic leukemic cells, elevated levels of IL-2 receptors were detectable. Release of IL-2 receptors seems to represent one of the major routes by which the receptors are cleared from the cell surface.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3102950     DOI: 10.1016/0161-5890(86)90147-1

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  8 in total

1.  Biological role of the soluble interleukin-2 receptor in sarcoidosis.

Authors:  Remi M M Vanmaris; Ger T Rijkers
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

2.  Concentrations of cytokines, soluble interleukin-2 receptor, and soluble CD30 in sera of patients with hepatitis B virus infection during acute and convalescent phases.

Authors:  Francisca Monsalve-De Castillo; Tania A Romero; Jesús Estévez; Luciana L Costa; Ricardo Atencio; Leticia Porto; Diana Callejas
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

3.  Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis.

Authors:  G Famularo; A Procopio; R Giacomelli; C Danese; S Sacchetti; M A Perego; A Santoni; G Tonietti
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

4.  Immunological markers of childhood fevers in an area of intense and perennial malaria transmission.

Authors:  N Hurt; M Thein; T Smith; G Bordmann; H Gallati; N Drees; M Tanner; N Weiss
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

5.  Interleukin 2 receptor in patients with localized and systemic parasitic diseases.

Authors:  O Josimovic-Alasevic; H Feldmeier; K Zwingenberger; G Harms; H Hahn; M Shrisuphanunt; T Diamantstein
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

6.  Phenotypic expression of integrin membrane receptors on spontaneously proliferating CD8 cells in human T-lymphotropic virus type II (HTLV-II)-infected individuals.

Authors:  R B Lal; D L Rudolph; T Rowe; T M Folks
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

7.  Decreased activity of interleukin-2 inhibitor in plasma of patients with systemic lupus erythematosus.

Authors:  E J Kucharz; S Sierakowski; J S Goodwin
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

8.  Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors.

Authors:  J E Nagel; R K Chopra; F J Chrest; M T McCoy; E L Schneider; N J Holbrook; W H Adler
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.